Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency

NCT03815396 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Alpha-1 Antitrypsin Deficiency
AATD

Interventions

DRUG: INBRX-101/rhAAT-Fc

Sponsor

Inhibrx Biosciences, Inc